Hypertension and risk of renal cell carcinoma among white and black Americans

Epidemiology

Volumn 22, Issue 6, 2011, Pages 797-804

  Colt, Joanne S ^a   Schwartz, Kendra ^b   Graubard, Barry I ^a   Davis, Faith ^c   Ruterbusch, Julie ^b   Digaetano, Ralph ^d   Purdue, Mark ^a   Rothman, Nathaniel ^a   Wacholder, Sholom ^a   Chow, Wong Ho ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d WESTAT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; EUROPEAN AMERICAN; FEMALE; HUMAN; HYPERTENSION; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE FACTORS; AGED; ANTIHYPERTENSIVE AGENTS; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; HYPERTENSION; INCIDENCE; KIDNEY NEOPLASMS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; RISK FACTORS; SEX FACTORS; UNITED STATES; YOUNG ADULT;

EID: 80053590901     PISSN: 10443983     EISSN: 15315487     Source Type: Journal    
DOI: 10.1097/EDE.0b013e3182300720     Document Type: Article

References (35)

1. Chow WH, Devesa SS. Contemporary epidemiology of renal cell cancer. Cancer J. 2008;14:288-301.
2. Chow WH, Devesa SS, Warren JL, Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281:1628-1631. (Pubitemid 29211773)
3. Cutler JA, Sorlie PD, Wolz M, Thom T, Fields LE, Roccella EJ. Trends in hypertension prevalence, awareness, treatment, and control rates in United States adults between 1988-1994 and 1999-2004. Hypertension. 2008;52:818-827.
4. Stojanovic M, Goldner B, Ivkovic D. Renal cell carcinoma and arterial hypertension. Clin Exp Nephrol. 2009;13:295-299.
5. Korn E, Graubard B. Analysis of Health Surveys. New York: Wiley; 1999.
6. Li Y, Graubard B, DiGaetano R. Weighting methods for population-based case-control studies with complex sampling. J Roy Statist Soc Ser C. 2011;60:165-185.
7. Rust KF, Rao JN. Variance estimation for complex surveys using replication techniques. Stat Methods Med Res. 1996;5:283-310. (Pubitemid 126559356)
8. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122:904-914. (Pubitemid 16207356)
9. Graubard BI, Fears TR. Standard errors for attributable risk for simple and complex sample designs. Biometrics. 2005;61:847-855.
10. Benichou J. A review of adjusted estimators of attributable risk. Stat Methods Med Res. 2001;10:195-216. (Pubitemid 32586161)
11. National Cancer Institute DSRPCSBrA2botN2s. Surveillance, Epidemiology, and End Results (SEER) Program SEER*Stat Database Incidence-SEER 9 Regs Limited-Use. Available at: www.seer.gov. 2009.
12. Flaherty KT, Fuchs CS, Colditz GA, et al. A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States). Cancer Causes Control. 2005;16:1099-1106. (Pubitemid 41356008)
13. Fraser GE, Phillips RL, Beeson WL. Hypertension, antihypertensive medication and risk of renal carcinoma in California Seventh-Day Adventists. Int J Epidemiol. 1990;19:832-838.
14. Nicodemus KK, Sweeney C, Folsom AR. Evaluation of dietary, medical and lifestyle risk factors for incident kidney cancer in postmenopausal women. Int J Cancer. 2004;108:115-121. (Pubitemid 37444453)
15. Weikert S, Boeing H, Pischon T, et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167:438-446. (Pubitemid 351264143)
16. Benichou J, Chow WH, McLaughlin JK, Mandel JS, Fraumeni JF Jr. Population attributable risk of renal cell cancer in Minnesota. Am J Epidemiol. 1998;148(5):424-430. (Pubitemid 28411099)
17. Chow WH, McLaughlin JK, Mandel JS, Wacholder S, Niwa S, Fraumeni JF Jr. Risk of renal cell cancer in relation to diuretics, antihypertensive drugs, and hypertension. Cancer Epidemiol Biomarkers Prev. 1995;4:327-331.
18. McCredie M, Stewart JH. Risk factors for kidney cancer in New South Wales, Australia. II. Urologic disease, hypertension, obesity, and hormonal factors. Cancer Causes Control. 1992;3:323-331.
19. McLaughlin JK, Chow WH, Mandel JS, et al. International renal-cell cancer study. VIII. Role of diuretics, other anti-hypertensive medications and hypertension. Int J Cancer. 1995;63:216-221.
20. Mellemgaard A, Niwa S, Mehl ES, Engholm G, McLaughlin JK, Olsen JH. Risk factors for renal cell carcinoma in Denmark: role of medication and medical history. Int J Epidemiol. 1994;23:923-930. (Pubitemid 24331206)
21. Weinmann S, Glass AG, Weiss NS, Psaty BM, Siscovick DS, White E. Use of diuretics and other antihypertensive medications in relation to the risk of renal cell cancer. Am J Epidemiol. 1994;140:792-804. (Pubitemid 24341991)
22. Yuan JM, Castelao JE, Gago-Dominguez M, Ross RK, Yu MC. Hypertension, obesity and their medications in relation to renal cell carcinoma. Br J Cancer. 1998;77:1508-1513. (Pubitemid 28190754)
23. Zucchetto A, Dal ML, Tavani A, et al. History of treated hypertension and diabetes mellitus and risk of renal cell cancer. Ann Oncol. 2007;18: 596-600. (Pubitemid 46359645)
24. Choi MY, Jee SH, Sull JW, Nam CM. The effect of hypertension on the risk for kidney cancer in Korean men. Kidney Int. 2005;67:647-652. (Pubitemid 40139856)
25. Chow WH, Gridley G, Fraumeni JF Jr, Jarvholm B. Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med. 2000;343: 1305-1311.
26. Vatten LJ, Trichopoulos D, Holmen J, Nilsen TI. Blood pressure and renal cancer risk: the HUNT Study in Norway. Br J Cancer. 2007;97: 112-114. (Pubitemid 47012085)
27. Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE. Hypertension, antihypertensive medication use, and risk of renal cell carcinoma. Am J Epidemiol. 1999;149:521-530. (Pubitemid 29130019)
28. Gago-Dominguez M, Castelao JE, Yuan JM, Ross RK, Yu MC. Lipid peroxidation: a novel and unifying concept of the etiology of renal cell carcinoma (United States). Cancer Causes Control. 2002;13:287-293. (Pubitemid 34438239)
29. Kaelin WG Jr. The von Hippel-Lindau gene, kidney cancer, and oxygen sensing. J Am Soc Nephrol. 2003;14:2703-2711. (Pubitemid 37305632)
30. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J. 2004;23:1949-1956. (Pubitemid 38902073)
31. Sharifi N, Farrar WL. Perturbations in hypoxia detection: a shared link between hereditary and sporadic tumor formation? Med Hypotheses. 2006;66:732-735. (Pubitemid 43181618)
32. Friis S, Sorensen HT, Mellemkjaer L, et al. Angiotensin-converting enzyme inhibitors and the risk of cancer: a population-based cohort study in Denmark. Cancer. 2001;92:2462-2470. (Pubitemid 33029093)
33. Fryzek JP, Poulsen AH, Johnsen SP, McLaughlin JK, Sorensen HT, Friis S. A cohort study of antihypertensive treatments and risk of renal cell cancer. Br J Cancer. 2005;92:1302-1306. (Pubitemid 40604409)
34. Giles T, Aranda JM Jr, Suh DC, et al. Ethnic/racial variations in blood pressure awareness, treatment, and control. J Clin Hypertens (Greenwich). 2007;9:345-354.
35. Cole RS, Hernan MA. Fallibility in estimating direct effects. Int J Epidemiol. 2002;31:163-165. (Pubitemid 34284920)